Nano Dimension (NNDM) Q4 2025 earnings review
Cost Cuts Deliver, But Inorganic Revenue Growth Obscures Stagnant Core
Nano Dimension is a company in deep transition. Management touted a 142% YoY revenue surge to $35.3M in Q4, but a look under the hood reveals this is entirely driven by the Markforged acquisition ($20.7M). Legacy organic revenue was exactly flat at $14.6M. However, we must give credit where it's due: aggressive cost-cutting is working. Stand-alone operating expenses collapsed 42% YoY, driving Adjusted EBITDA losses down to $9.8M—a massive sequential improvement. With $459.6M in cash and an imminent 'strategic alternatives' announcement slated for Q2 2026, the company is either polishing the asset for a sale or preparing to go private.
🐂 Bull Case
Drastic headcount and portfolio rationalization (cutting 42% of stand-alone OpEx) has narrowed the Adjusted EBITDA loss to single-digits ($9.8M) for the first time in recent history.
With $459.6M in cash and marketable securities, the company's enterprise value is deeply negative, providing immense optionality for the upcoming strategic review.
🐻 Bear Case
Despite management's claims of 'momentum,' the core legacy business generated $14.6M in Q4—exactly the same as Q4 2024. All top-line growth is purchased.
The Board halted share repurchases despite the stock trading well below cash value, frustrating investors and signaling cash-hoarding ahead of an uncertain Q2 strategic decision.
⚖️ Verdict: ⚪
Neutral. Management is finally enforcing financial discipline, but manufacturing headlines with acquired revenue while the core business stagnates is a red flag. The true value hinges entirely on the Q2 strategic alternatives outcome.
Key Themes
The '142% Growth' Illusion
Management's press release heavily promoted a 142% year-over-year revenue increase. However, an analyst rightly called out the misleading nature of this headline on the call: Markforged contributed $20.7M, meaning legacy Nano Dimension revenue was roughly $14.6M, completely flat compared to Q4 2024. Growth in the core business is stable at best, not accelerating.
Draconian Cost Controls Finally Bite
The integration and rationalization playbook is yielding hard results. Consolidated Q4 OpEx dropped 6% sequentially to $27.3M. More impressively, legacy Nano Dimension OpEx plummeted 42% YoY. Adjusted Gross Margins also expanded sequentially to 49.7% from 47.4% in Q3. This operational leverage is the primary driver behind the rapidly decelerating EBITDA losses.
Suspended Buybacks Spark Investor Frustration
After repurchasing 14.4M shares in H2 2025 for ~$24.9M, management abruptly halted the program. On the call, management argued there are 'better uses for our money,' deflecting directly to the Q2 strategic review. Given the stock trades at a massive discount to its $459.6M cash pile, this decision was openly criticized by analysts as ignoring immediately accretive returns.
Defense Sector Adoption and Tactical Edge Manufacturing
Nano Dimension is successfully positioning its FX10 and FX20 systems for 'tactical edge' manufacturing in the defense sector. The ability of the FX10 to print both high-performance composite and metal parts on the same system is a significant hardware innovation, allowing military units to produce mission-critical replacement parts on-demand in disconnected or contested environments.
Material Weakness in Internal Controls
Management disclosed a material weakness in internal controls over financial reporting related to the accounting and valuation of its complex 2025 business combinations (Markforged and the subsequent bankruptcy of Desktop Metal). While they claim no historical restatements are necessary, this adds a layer of risk and administrative drag as they transition to U.S. GAAP reporting.
Macro: Tariffs Easing, but Capex Hesitation Remains
Management noted that tariff-related uncertainty in Europe and the US eased as the year progressed. However, they cited that 'cautious capital spending continues to create variability in certain sectors,' meaning the macro environment for high-ticket hardware purchases remains challenging.
Other KPIs
Cash burn is decelerating. The balance dropped $55.9M sequentially from Q3 ($515.5M), but roughly $44.2M of this drop was driven by share repurchases ($19.8M) and mark-to-market declines on marketable securities ($24.4M). True operational cash burn is tightening significantly.
The SM Tech division (advanced electronics manufacturing) expanded relationships with Tier 1 customers. Management highlighted specific innovations in their FOX Ultra and PUMA Ultra systems, which enhance high-speed solder paste jetting—critical for increasingly complex PCB production.
Guidance
Stable. The midpoint of $135M represents >30% YoY growth vs FY25 ($102.4M), but FY25 only had Markforged for ~8 months. If we annualize Q4's run rate ($35.3M x 4 = $141M), this guidance implies completely flat to slightly down sequential sales throughout 2026. Management expects a modest H1 ramping into a stronger H2.
Stable. The midpoint of 47.0% is directly in line with FY25's 46.9% average, but actually implies a slight deceleration compared to the 49.7% achieved in Q4 2025. This suggests conservative pricing power assumptions.
Accelerating slightly on an absolute basis. FY25 OpEx was $101M. The projected increase accounts for a full 12 months of Markforged expenses vs 8 months in 2025, meaning on a run-rate basis, the company is still actively cutting legacy costs.
Improving. Narrowing from a $53.2M loss in FY25. However, this full-year guidance suggests an average quarterly loss of ~$11.2M, which is a step backward from the highly successful $9.8M loss achieved in 25Q4. Management is leaving themselves room for error.
Key Questions
Strategic Alternatives Reality Check
You halted share buybacks to preserve cash for the strategic alternatives review. If taking the company private or issuing a massive special dividend were the primary options, wouldn't buying shares at a discount now be accretive to either scenario? What is the actual intended use of this cash?
Organic Growth Stagnation
Legacy Nano Dimension organic revenue was completely flat year-over-year in Q4 at $14.6 million. What is the organic growth assumption embedded in your 2026 guidance of $130-$140 million?
Material Weakness Remediation
Regarding the material weakness related to business combinations, what specific external valuation or accounting resources are you onboarding to ensure the U.S. GAAP transition in H1 2026 doesn't result in delayed filings?